Research output per year
Research output per year
Full professor, prof. dr.
Heidelberglaan 100, UMC Utrecht
3584 CX Utrecht
Netherlands
Research activity per year
Karijn Suijkerbuijk is a translational medical oncologist with special interest in melanoma and immunotherapy. During her PhD, she performed research on tumor epigenetics in breast cancer in the lab of Professor Saraswati Sukumar at the Sidney Kimmel Cancer Center at Johns Hopkins University. Dr. Suijkerbuijk currently participates in multiple phase II and III clinical trials on immune checkpoint inhibitors. She published papers in Oncogene, Annals of Oncology and JNCI, received research grants from KWF and NWO and was awarded an ASCO Merit Award. Her current research focuses on clinical and immunological parameters assoaciated with immune related adverse events during checkpoint inhibition and clinicopathological factors associated with checkpoint inhibitor response.
2007 Research year for residents (UU2007-3977) KWF
2008 Translational grant KWF (UU-2008-4217
2008 AGIKO stipend, ZonMW
2008 ASCO Merit Award
2018 ZonMW goed gebruik geneesmiddelen
2023-... Scientific Steering Committee ESMO 2024 (melanoma track chair)
2023-... Chair ESMO Melanoma Faculty
2022-... Member ESMO Real World Data Working Group
2022 Research funding Bristol Myers Squibb
2021-.. Scientific advisory board Maarten vd Weijden foundation
2021-.. ESMO melanoma faculty
2021 Organizer and chair Oncode Melanoma Workshop
2021 Reserach funding TigaTx
2020-.. Data Safety Monitoring Board CHOPIN study (LUMC)
2020 Data Safety Monitoring Board ICRA study (NKI)
2020-.. Member Dutch working group Cancer in Pregnancy
2020-.. Congress organization Immune-oncology symposium
2020 Research funding Novartis
2019-.. Scientific chair Dutch Melanoma Treatment Registry (DMTR)
2019-.. Advisory board member patient society Stichting Melanoom
2019-.. Board member Dutch Melanoma Tumor Focus Group
2018-.. Invited discussant Medtalks
Associate Professor, University Medical Center (UMC) Utrecht
Award Date: 1 Nov 2019
research funding Genmab - AI onderzoekssamenwerking in Health Holland project dat door Genmab financieel wordt ondersteund - Genmab
1 Nov 2023 → 31 Dec 3999
ESMO Melanoma Faculty Chair - melanoomexpertise - European Society for Medical Oncology
1 Jan 2023 → 31 Dec 2024
Scientific Steering Committee ESMO 2024 (melanoma track chair) - melanoom expertise - European Society for Medical Oncology
1 Jan 2023 → 31 Dec 2024
ESMO melanoma faculty - expertise melanoom - European Society for Medical Oncology
13 Jun 2022 → 31 Dec 3999
Lid real world data working group ESMO - onderzoek patientcohorten - European Society for Medical Oncology
10 Jun 2022 → 31 Dec 3999
Lid wetenschappelijke adviesraad - ervaring onderzoek - Maarten van der Weijden foundation
10 Jun 2022 → 31 Dec 3999
Adviesraad stichting melanoom (sinds 2019) - Vanuit expertise als melanoombehandelaar - Stichting melanoom
9 Jun 2022 → 31 Dec 3999
Lid Data Safety Monitoring Committee CHOPIN studie (vanaf 2020; studie gesponsord door BMS) - onderzoekservaring immuuntherapie - LUMC
9 Jun 2022 → 31 Dec 3999
Voorzitter wetenschappelijke commissie - Kwaliteitsverbetering en onderzoek op het gebied van melanoomzorg - Dutch Melanoma Treatment Registry (DICA)
6 Jun 2022 → 31 Dec 3999
Adviesgroep kanker in de zwangerschap - Expertise melanoom en immuuntherapie - Adviesgroep kanker in de zwangerschap
1 Jun 2022 → 31 Dec 3999
Onderzoeksfinanciering UNICIT-project door Bristol Myers Squibb - onderzoek immuuntherapie - UMC Utrecht
1 Apr 2022 → 1 Jan 2025
Organisatie/voorzitter jaarlijks immuno-oncologie symposium - expertise en onderzoek immuunoncologie - Immuno-oncologie symposium
1 Jan 2020 → 31 Dec 3999
Bestuurslid Tumorfocusgroep melanoom - expertise melanoom - Tumorfocusgroep melanoom
1 Jan 2019 → 31 Dec 3999
medisch expert bij melanoom nascholing en congresjournaal ASCO/ESMO - expertise melanoom - Medtalks
1 Jan 2018 → 31 Dec 3999
Research output: Contribution to journal › Article › Academic › peer-review
Research output: Contribution to journal › Article › Academic › peer-review
Research output: Contribution to journal › Article › Academic › peer-review
Research output: Contribution to journal › Article › Academic › peer-review
Research output: Contribution to journal › Article › Academic › peer-review